RxDoctor Payments Data

Evan Katzel, MD

Plastic Surgery · Philadelphia, PANPI 1831487735

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $282,795 of the $337,723 with a category attached, or 83.7%. TELA Bio, Inc. accounts for 96.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $137,196 and has fallen 54.8% since, to $62,053 in 2025. Among plastic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$337,723in general payments, 2019–2025

Across 390 payments — averaging $865.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$326K
  • Davol Inc.$4K
  • Motiva USA, LLC$3K
  • Bimini Technologies LLC$2K
  • RTI Surgical, Inc$1K
  • Sientra, Inc.$488
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$282,79584%
  • Speaking & faculty fees$6,9002%
  • Travel & lodging$34,39310%
  • Food & beverage$13,6344%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$337,723 in reported general payments places this provider in the 95th percentile of 196 plastic surgery providers in Pennsylvania.

See all plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$45,827
Medicare patients
33
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →